The Centers for Medicare & Medicaid Services unveiled a new program for alternative payment model participants that would allow clinicians to use products containing CBD as part of patient care plans. In response, the Food and Drug Administration vowed not to further restrict the sale of oral hemp products.
A group of Australian researchers have developed a blood test that can accurately detect melanoma with 79 percent accuracy in its earliest stages. Results of their study were published on July 17 in Onocotarget.
ECRI Institute, an independent nonprofit organization, has stepped in to maintain a national database of clinical best practices after HHS cut funding to the resource.
Considering healthcare is often, literally, a matter of life and death, disagreements between patient and physician can escalate. A recent feature in USA Today looked at one case to explore the blurred line between consumer advocacy and online harassment.
The FDA unveiled a new plan to enable market competition for biologics and biosimilars Wednesday, July 18, as part of a larger shift to lower drug prices across the healthcare system.
